The Vietnam Aquaculture Vaccines Market is positioned for strong expansion from 2025 to 2035, supported by the country’s rapidly growing seafood sector, rising emphasis on disease prevention, and sustained export demand. With an estimated market value of USD 72.6 million in 2025 and a projected CAGR of 7.8%, Vietnam is set to emerge as one of Asia’s most dynamic aquaculture vaccine hubs over the coming decade.
Explore trends before investing – request a sample report today!
https://www.futuremarketinsights.com/reports/sample/rep-gb-20175
Vietnam’s dominance as a leading global seafood exporter places substantial importance on disease mitigation strategies in shrimp, pangasius, and tilapia farming. Government policies encouraging reduced antibiotic use, coupled with local and international investment in R&D, are helping shift the industry toward sustainable, preventive healthcare solutions. Vaccines are increasingly becoming a core component of disease management, boosting yields and enhancing export competitiveness.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates –
https://www.futuremarketinsights.com/reports/brochure/rep-gb-20175
Market Drivers Strengthening Growth Momentum
Vietnam’s aquaculture sector continues to evolve, with several structural and market-driven factors accelerating vaccine adoption:
- Growing integration of vaccination protocols to reduce antibiotic use
- Rising disease incidence in high-value species, particularly shrimp and pangasius
- Expanding collaborations between global leaders and Vietnamese institutions
- Increasing awareness among farmers about long-term productivity benefits
- Investments in vaccine delivery methods, including oral and immersion technologies
The intensifying focus on preventive approaches is reshaping farm-level practices, improving product quality, and aligning Vietnam with global food safety standards.
Shifting Toward Preventive Aquaculture Health
More farms across Vietnam are replacing antibiotics with advanced vaccination strategies. This transition supports:
- Compliance with international food safety regulations
- Enhancement of disease management, particularly for pathogens affecting shrimp and catfish
- Reduction of antibiotic resistance risks
Farmers are increasingly adopting science-backed solutions to meet export requirements and secure higher yields.
Focus on Core Aquaculture Segments
Vietnam’s aquaculture industry remains driven by three key species groups:
- Shrimp Farming: High demand for vaccines targeting white spot syndrome virus (WSSV) and Vibrio infections
- Pangasius Farming: Broader adoption of vaccines combatting Aeromonas and Edwardsiella bacteria
- Tilapia Farming: Rising demand for Streptococcus-targeted vaccines as tilapia exports expand
Each segment continues to attract both domestic and foreign R&D investments.
Vaccine Types Driving Market Segmentation
The Vietnam Aquaculture Vaccines Market is categorized into four major vaccine types:
- Inactivated Vaccines: Leading the market with strong safety profiles and wide use in pangasius and tilapia
- Live Attenuated Vaccines: Gaining popularity due to long-term immunity benefits for high-value species
- DNA Vaccines: Emerging as a next-generation solution for viral challenges like iridovirus
- Multivalent Vaccines: Preferred by farmers for convenience and cost efficiency
These options allow farmers to tailor solutions according to species needs, disease prevalence, and production scale.
Competitive Landscape and Market Concentration
Vietnam’s market is moderately consolidated, with Tier 1 players controlling the majority share:
- Tier 1: MSD Animal Health, Zoetis, Elanco – holding 60% share with advanced, globally recognized products
- Tier 2: NAVETCO, Vemedim – contributing 30% through cost-effective local production
- Tier 3: Benchmark Animal Health, Hipra – offering specialized multivalent and DNA vaccine solutions
Collaborations between multinational manufacturers and Vietnamese research institutions continue to strengthen vaccine accessibility and innovation.
Key Growth Drivers
- Export-Driven Quality Requirements: Rising global demand for Vietnamese shrimp and pangasius
- Government Support: Subsidies and training programs promoting sustainable aquaculture
- Disease Management Needs: Frequent outbreaks increasing vaccine dependency for loss prevention
These factors collectively anchor long-term demand across Vietnam’s aquaculture ecosystem.
Challenges Impacting Market Expansion
Despite strong progress, several barriers persist:
- Limited awareness among small-scale farmers
- High upfront costs compared to traditional antibiotics
- Cold chain storage and transportation constraints in remote regions
Addressing these gaps will be essential to unlocking full adoption potential.
Latest Industry Developments
- Jul 2024 – Elanco: Collaborated with local institutes to develop multivalent vaccines for shrimp and tilapia
- Sep 2024 – Vemedim: Expanded manufacturing capacity to meet rising domestic needs
- Nov 2024 – Hipra: Introduced a DNA vaccine for iridovirus in premium fish species
These advancements highlight Vietnam’s accelerating innovation landscape.
Future Outlook: Strong Growth Expected Through 2035
By 2035, Vietnam’s aquaculture vaccines market is projected to reach USD 165.4 million, propelled by advancements in DNA and multivalent vaccines, improved farm-level awareness, and government-backed sustainability initiatives. As Vietnam strengthens its position as a global seafood supplier, vaccine adoption will play an increasingly central role in disease prevention, yield optimization, and export competitiveness.
Why Choose FMI – Empowering Decisions that Drive Real-World Outcomes:
https://www.futuremarketinsights.com/why-fmi
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
